CHARLES RIVER LABORATORIES (CRL)

Interesting CRL Put And Call Options For August 2025

Which S&P500 stocks are gapping on Friday?

Looking for the S&P500 stocks that are experiencing notable gaps on Friday? Find out which stocks are gapping up and gapping down in the S&P500 index during today's session.

These S&P500 stocks are moving in today's session

Top movers analysis one hour before the close of the markets of S&P500 on 2024-12-09: top gainers and losers in today's session.

Charles River Introduces Global Biotech Incubator Program

Charles River Laboratories to Present at Evercore ISI Investor Conference

Thursday Sector Laggards: Industrial, Healthcare

Wednesday Sector Laggards: Utilities, Healthcare

Charles River Laboratories to Present at UBS and Jefferies Conferences

Charles River Laboratories Announces Third-Quarter 2024 Results

December 20th Options Now Available For Charles River Laboratories International (CRL)

Charles River Launches New Retrogenix® Non-Human Protein Library

Charles River Laboratories International Moves Up In Market Cap Rank, Passing Hasbro

Charles River Laboratories Schedules Third-Quarter 2024 Earnings Release and Conference Call

Comparing Bitcoin Versus Charles River Reveals New Low

Charles River Provides Translational Expertise at Neuroscience 2024

Charles River and Lundbeck Enter Agreement Utilizing AI-Powered Logica® to Advance the Discovery of Novel Drugs for Neurological Disease

Charles River Laboratories and CEBINA Announce Strategic Collaboration to Accelerate Cutting Edge Neuroscience Research

Charles River and Insightec Announce Strategic Collaboration to Advance Therapeutic Development Utilizing Focused Ultrasound in Neuroscience

/PRNewswire/ -- Charles River Laboratories International, Inc. (NYSE: CRL) and Insightec, a global healthcare company dedicated to using focused ultrasound to...

Charles River and Insightec Announce Strategic Collaboration to Advance Therapeutic Development Utilizing Focused Ultrasound in Neuroscience

Charles River Laboratories to Present at Baird and Morgan Stanley Conferences

CHARLES RIVER ALERT: Bragar Eagel & Squire, P.C. is Investigating Charles River Laboratories International, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

Wednesday Sector Laggards: Healthcare, Materials

Agree To Purchase Charles River Laboratories International At $155, Earn 5.8% Using Options

CRL Crosses Below Key Moving Average Level

Charles River Labs Plummets 17% On 'Bleaker' Expectations For 2024

Pharmaceutical demand hit the skids in the second quarter and isn't expected to improve this year.

Charles River Laboratories Announces Second-Quarter 2024 Results